HydroPICC 5Fr Dual Lumen, 80cm guidewire - Basic Kit, Product Model Number 80002002
FDA Recall Z-0114-2024 · Posted 2023-10-13
Advertisement
Recalling FirmAccess Vascular, Inc
Recall StatusOpen, Classified
Product CodeLJS
Date Initiated2023-08-31
Product Quantity58 total
Reason for Recall
Specific lots of the Dual Lumen HydroPICC Kits were provided with the incorrect revision of the Instructions For Use (IFU) which do not include the following warnings statement: HydroPICC Dual Lumen Catheter is for adult use only. There is a potential risk to health should the HydroPICC Dual Lumen Catheter be used in an inadequately sized vessel. There have been no reported adverse events to date.
Firm Action
An Urgent Medical Device Correction notification letter dated 8/25/23 was sent to customers.
Our records indicate that your facility has received kits from the affected lots. We are contacting you to provide information on action to take to ensure patient safety.
- Product that has already been used: No action required. All catheters to date have been used with adult patients.
- Product that has not been used: The kit does not have the current IFU. Please refer to the Rev C. IFU provided with this letter. Also, the Patient Information Card, part number LS-067, includes a barcode link to the current revision of the IFU on AVIs website.
The following page identifies the shipments you have received with these impacted lots. Please forward this notice in the event the affected product was further distributed. We will contact you to identify the number of kits that are currently in your inventory and determine the appropriate correction with your input, in a timely manner.
If you have any questions about this communication, please contact us at 781-538-6594.
Root Cause
Error in labeling
Distribution Pattern
US Nationwide distribution in the states of IL, TX.
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement